Consistently, flow cytometry (Figure 3B-C) confirmed a higher percentage of CD8+ T cells in SMGs (Figure 3D, F, left panels) and spleens (Figure 3E, G, left panels), respectively, in tumor-bearing Atg5flox/flox mice at both Day 14 (Figure 3D-E) and Day 25 (Figure 3F-G). This evidence concerns the gene CD8A and neoplasm.